Abstract Session: Novel therapeutics and immunosuppression strategies 2
Wednesday September 25, 2024 from 08:00 to 09:15
Üsküdar 3
Click for details – page will open in a new window
Moderators
Prof. Caner Süsal, Turkey
Uchida Koichiro, Japan
Lectures
406.a Microbiome modification for immune regulation
Prof. Maria-Luisa Alegre, United States
406.1 YTHDF3 regulates IGF1R to aggravate pancreatic islets cellular aging and dysfunction
Dr. Sun Qin, People's Republic of China
406.2 Graft protein shows a distinct signature in donor-specific antibody positive kidney transplant recipients with antibody-mediated rejection
Dr. Kieran Manion, Canada
406.3 The role of interleukin 27 in donor specific alloantibody responses
Dr. Jose Ignacio Valenzuela, Argentina
406.4 Donor-specific immunoglobulin E augments alloreactive responses in a CD23-dependent manner
Mrs. Anna Weijler, Austria
406.5 Bile levels of keratin 19 from donations after circulatory death are associated with early graft dysfunction
Davide Ghinolfi, Italy
406.6 Bcl6 inhibitors – a novel immunosuppressive strategy disrupting T-B collaboration in alloimmune responses
Dr. Louisa Steines, Germany
406.7 Inducing Long-Term Heart Allograft Tolerance Through Selective Treg Expansion by IL-2 Complex Treatment
Mr. Laurenz L Wolner, Austria